Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.10 -0.10 (-3.13%)
At close: Oct 22, 2026 · 4:00 PM EDT

Apimeds Pharmaceuticals US (APUS) Other Accumulated Expenses (2023 - 2026)

Updated

Apimeds Pharmaceuticals US's Other Accumulated Expenses was $1.24 million in Q2 2026, compared with $100.00 a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) Other Accumulated Expenses (2023 - 2026) Analysis & Trends

At the end of FY2025, Other Accumulated Expenses at Apimeds Pharmaceuticals US came in at $27,952, down 63.5% from FY2024.

  • In earlier years, Other Accumulated Expenses was $76,500 in FY2024 (+11.1%) and $68,878 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Apimeds Pharmaceuticals US 4.68 Mn -14.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.24 Mn
Dec 31, 2025 27,952.00
Sep 30, 2025 100.00
Jun 30, 2025 100.00
Mar 31, 2025 117,899.00
Dec 31, 2024 76,500.00
Dec 31, 2023 68,878.00
API Access

Apimeds Pharmaceuticals US Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=APUS&period=max&api_key=YOUR_API_KEY